Loading company…
VM Discovery uses computational methods to design and optimize drug candidates.
VM Discovery develops drug candidates using its VMOptimizer platform, which applies computational methods to support precision medicine research. Founded in 2001, the company is based in Fremont, US, and serves pharmaceutical companies, particularly in North America and Europe. In July 2014, it raised USD 7.87 mn in Series D funding from Amkey Ventures and others. Jay Wu is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in